Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor State
15/12/2015 Racotumomab-alum cancer vaccine for solid tumors in pediatric patients CIM Registered
14/12/2015 CIMAvax-EGF vaccine Predictor Phase IV CIM Registered outdated
04/12/2015 Dose scale-up and cohort expansion with the therapeutic mAb 14F7 CIM Registered outdated
04/12/2015 Study of the meningococcal ACW135 polysaccharide vaccine FINLAY Registered
19/11/2015 EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS CLS Registered
08/10/2015 Itolizumab for Moderate-to-Severe Psoriasis-phase 3 CIM Registered
25/09/2015 Seawater-Rhinitis-Children-Phase III UDEA Registered
08/07/2015 Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer CIM Registered
24/06/2015 SURFACEN in ARDS. Adults. Phase IV CENSA Registered
22/05/2015 Itolizumab for Relapsing Remitting Multiple Sclerosis CIM Registered
22/05/2015 Safety and pharmacokinetics of CIGB-552 CIGB Registered
12/05/2015 Vitamin E/ Platinum salts CIDEM Registered
13/04/2015 Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. BIOCEN Registered
13/04/2015 Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II BIOCEN Registered
08/04/2015 Combifer vs Trofin phase II in anemic pregnant women. BIOCEN Registered
08/04/2015 THERESA-5 Study CIGB Registered
14/11/2014 Study in Hematological Malignancies CIGB Registered
10/11/2014 CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. CIGB Registered
06/11/2014 Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . FINLAY Registered
02/11/2014 NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II CIMAB Registered